HealthCap, Versant et al. lead SEK 437m series-B for Aprea
Swedish biotech company Aprea has raised a SEK 437m series-B led by Versant Ventures, 5AM Ventures and Healthcap, alongside additional capital providers.
More on Early-stage
Icelandic company Lucinity raises $6.1m in series-A round
Company has raised $9m in total at the series-A stage, from new and existing investors
Fund+ leads €23m series-A for Exevir
Exevir will commit to the international effort to pursue new treatment for Covid-19
Life Science Partners et. al in series-A round for Vico Therapeutics
Biotech startup will use the proceeds to further advance its therapy
Fortunis invests up to £15m in Sportside
Social app allows people to find sports players of a similar age, ability and geography
Latest News
UCL Technology Fund 2 holds first close on £100m
UCL Technology Fund closed on £50m in January 2016 and is now fully deployed
CMS hires five in Polish transactions team
All five lawyers have joined from Clifford Chance and will focus on mandates for private equity firms
Investindustrial’s Italcanditi buys Ortofrutticola Del Mugello
Deal is part of a buy-and-build strategy pursued by the GP to strengthen Italcanditi's market position
Verium-backed Tavola acquires Frische und Service
Tavola already owns Frische und Service's Swiss market peer Ceposa, which it acquired in 2018